1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Radiopharmaceutical Theranostics Market – by Product Type

1.3.2        North America Radiopharmaceutical Theranostics Market – by Radioisotope

1.3.3        North America Radiopharmaceutical Theranostics Market – by Source

1.3.4        North America Radiopharmaceutical Theranostics Market – by Application

1.3.5        North America Radiopharmaceutical Theranostics Market – by Indication

1.3.6        North America Radiopharmaceutical Theranostics Market – by End User

1.3.7        North America Radiopharmaceutical Theranostics Market – by Country

2.           Radiopharmaceutical Theranostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Radiopharmaceutical Theranostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Expert’s Opinion

5.           North America Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidence of Cancer

5.1.2        Rising Application in Treatment of Cardiovascular Disorders

5.2         Market Restraints

5.2.1        Regulatory Challenges for Approval of Radiopharmaceutical Theranostics

5.3         Market Opportunities

5.3.1        Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies

5.4         Future Trends

5.4.1        Radiopharmaceutical Theranostics in Nuclear Medicine

5.5         Impact Analysis

6.           Radiopharmaceutical Theranostics Market – North America Analysis

6.1         North America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7.           North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

7.2.1        Positron Emission Tomography (PET) Tracers

7.2.1.1          Overview

7.2.1.2          Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.2        Beta Emitters

7.2.2.1          Overview

7.2.2.2          Beta Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

7.2.3        Alpha Emitters

7.2.3.1          Overview

7.2.3.2          Alpha Emitters: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1         Overview

8.2         Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)

8.2.1        Technetium-99

8.2.1.1          Overview

8.2.1.2          Technetium-99: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.2        Gallium-68

8.2.2.1          Overview

8.2.2.2          Gallium-68: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.3        Iodine-131

8.2.3.1          Overview

8.2.3.2          Iodine-131: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.4        Iodine-123

8.2.4.1          Overview

8.2.4.2          Iodine-123: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.5        Fluorine-18 (18F)

8.2.5.1          Overview

8.2.5.2          Fluorine-18 (18F): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.6        Yttrium 90 (Y-90)

8.2.6.1          Overview

8.2.6.2          Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.7        Lutetium (LU) 177

8.2.7.1          Overview

8.2.7.2          Lutetium (LU) 177: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.8        Copper (CU) 67

8.2.8.1          Overview

8.2.8.2          Copper (CU) 67: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.9        Copper (CU) 64

8.2.9.1          Overview

8.2.9.2          Copper (CU) 64: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

8.2.10     Others

8.2.10.1       Overview

8.2.10.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Radiopharmaceutical Theranostics Market Analysis – by Source

9.1         Overview

9.2         Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)

9.2.1        Nuclear Reactors

9.2.1.1          Overview

9.2.1.2          Nuclear Reactors: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

9.2.2        Cyclotrons

9.2.2.1          Overview

9.2.2.2          Cyclotrons: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Radiopharmaceutical Theranostics Market Analysis – by Application

10.1      Overview

10.2      Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)

10.2.1     Targeted Therapeutic (Rx)

10.2.1.1       Overview

10.2.1.2       Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

10.2.2     Companion Diagnostic (CDx)

10.2.2.1       Overview

10.2.2.2       Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Radiopharmaceutical Theranostics Market Analysis – by Indication

11.1      Overview

11.2      Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)

11.2.1     Oncology

11.2.1.1       Overview

11.2.1.2       Oncology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.2     Neurology

11.2.2.1       Overview

11.2.2.2       Neurology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.3     Cardiology

11.2.3.1       Overview

11.2.3.2       Cardiology: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.4     Others

11.2.4.1       Overview

11.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.        North America Radiopharmaceutical Theranostics Market Analysis – by End User

12.1      Overview

12.2      Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)

12.2.1     Hospitals

12.2.1.1       Overview

12.2.1.2       Hospitals: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.2     Diagnostic Imaging Centers

12.2.2.1       Overview

12.2.2.2       Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3     Academic & Research Institutes

12.2.3.1       Overview

12.2.3.2       Academic & Research Institutes: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

12.2.4     Others

12.2.4.1       Overview

12.2.4.2       Others: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.        North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 – by Country Analysis

13.1      North America: Radiopharmaceutical Theranostics Market

13.1.1     Overview

13.1.1.1       United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.1.1       Overview

13.1.1.1.2       United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.1.3       United States Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.1.1.4       United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.1.1.5       United States Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.1.1.6       United States Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.1.1.7       United States Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.1.1.8       United States Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.1.2       Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.2.1       Overview

13.1.1.2.2       Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.2.3       Canada Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.1.2.4       Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.1.2.5       Canada Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.1.2.6       Canada Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.1.2.7       Canada Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.1.2.8       Canada Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

13.1.1.3       Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.3.1       Overview

13.1.1.3.2       Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

13.1.1.3.3       Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019–2028 (US$ Million)

13.1.1.3.4       Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019–2028 (US$ Million)

13.1.1.3.5       Mexico Radiopharmaceutical Theranostics Market, by Source, 2019–2028 (US$ Million)

13.1.1.3.6       Mexico Radiopharmaceutical Theranostics Market, by Application, 2019–2028 (US$ Million)

13.1.1.3.7       Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019–2028 (US$ Million)

13.1.1.3.8       Mexico Radiopharmaceutical Theranostics Market, by End User, 2019–2028 (US$ Million)

14.        Radiopharmaceutical Theranostics Market – Industry Landscape

14.1      Overview

14.2      Growth Strategies in the Radiopharmaceutical Theranostics Market

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        Company Profiles

15.1      Bayer AG

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      GE HealthCare Technologies Inc

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Curium

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      Lantheus Medical Imaging, Inc.

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      Telix Pharmaceuticals Ltd.

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Cardinal Health Inc

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Advanced Accelerator Applications S.A.

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      Jubilant Radiopharma

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9      Theragnostics

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

15.10   NuView Life Sciences

15.10.1  Key Facts

15.10.2  Business Description

15.10.3  Products and Services

15.10.4  Financial Overview

15.10.5  SWOT Analysis

15.10.6  Key Developments

16.        Appendix

16.1      About The Insight Partners

16.2      Glossary of Terms

LIST OF TABLES

Table 1.             United States Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             United States Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 3.             United States Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 4.             United States Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 5.             United States Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 6.             United States Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Canada Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Radiopharmaceutical Theranostics Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Radiopharmaceutical Theranostics Market, by Radioisotope – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Radiopharmaceutical Theranostics Market, by Source – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Radiopharmaceutical Theranostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Mexico Radiopharmaceutical Theranostics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Mexico Radiopharmaceutical Theranostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 20.          Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market

Table 21.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Radiopharmaceutical Theranostics Market Segmentation

Figure 2.           North America Radiopharmaceutical Theranostics Market, by Country

Figure 3.           North America Radiopharmaceutical Theranostics Market Overview

Figure 4.           Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market

Figure 5.           US Expected to Show Remarkable Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           North America Experts’ Opinion

Figure 8.           North America Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints

Figure 9.           North America Radiopharmaceutical Theranostics Market – Revenue Forecast and Analysis – 2020–2028

Figure 10.        North America Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)

Figure 11.        Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Beta Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Alpha Emitters: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        North America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)

Figure 15.        Technetium-99: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Gallium-68: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Iodine-131: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Iodine-123: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Yttrium 90 (Y-90): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Lutetium (LU) 177: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Copper (CU) 67: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Copper (CU) 64: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        North America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)

Figure 26.        Nuclear Reactors: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Cyclotrons: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        North America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)

Figure 29.        Targeted Therapeutics (Rx): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Companion Diagnostics (CDx): North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        North America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)

Figure 32.        Oncology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Neurology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Cardiology: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        North America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)

Figure 37.        Hospitals: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        Diagnostic Imaging Centers: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        Academic & Research Institutes: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028  (US$ Million)

Figure 40.        Others: North America Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 41.        North America: Radiopharmaceutical Theranostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 42.        North America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)

Figure 43.        United States: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Canada: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 45.        Mexico: Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 46.        Growth Strategies in the Radiopharmaceutical Theranostics Market